iShares MSCI United Kingdom (FTSE) vs Heartflow Inc. Common Stock — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $47.5 (market cap $3.71B), while Heartflow Inc. Common Stock trades at $48.78 (market cap $4.30B). The key difference: Heartflow Inc. Common Stock is the larger of the two by market cap, and Heartflow Inc. Common Stock is trading nearer its 52-week high, iShares MSCI United Kingdom (FTSE) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI United Kingdom (FTSE) for 48 Days and Heartflow Inc. Common Stock for 0 Days on average.
| EWU | HTFL | |
|---|---|---|
Market Cap | $3.71B | $4.30B |
Volume | 728,527 | 1,616,039 |
Sector | Broad Market / Factor | Health |
52-Week High | $49.39 | $52.21 |
52-Week Low | $41.34 | $20.49 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | — | $4.17B |
Signals from Pluang's Aura AI — not financial advice
EWU trades at $46.82 with a modest 0.26% daily gain, though technical indicators signal bearish momentum with moving averages and overall signals pointing downward. The stock faces headwinds from UK economic concerns including rising gilt yields and inflation pressures. Recent news highlights volatility in UK markets, particularly affecting banking and housing sectors, creating a challenging environment for this UK-focused ETF.
The outlook remains cautious as rising UK borrowing costs and persistent inflation create macroeconomic headwinds. While housebuilder stocks have shown recent strength on government support programs, broader market sentiment is weighed down by energy price shocks and ECB rate hikes affecting European markets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →